To evaluate the usefulness of routine monitoring of serum lamotrigine concentration.
DATA SOURCE:
Literature was accessed through MEDLINE (1990–January 2001). Key search terms included lamotrigine, pharmacokinetics, and epilepsy.
DATA SYNTHESIS:
A decision-making algorithm was used to evaluate the clinical evidence to support or refute the routine use of serum lamotrigine concentrations to adjust doses. The value of serum lamotrigine concentration monitoring remains controversial, primarily because clear relationships between concentration and pharmacologic response (either efficacy or toxicity) have not been demonstrated.
CONCLUSIONS:
Serum concentration monitoring of lamotrigine is not recommended as a tool for routine dose adjustment.
EnsomMHHDavisGACroppCDEnsomRJ. Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes? Clin Pharmacokinet1998;34: 265–79.
2.
PeruccaE. Is there a role for therapeutic drug monitoring of new anticonvulsants?Clin Pharmacokinet2000;38: 191–204.
3.
GeorgeSWoodAJBraithwaiteRA. Routine therapeutic monitoring of lamotrigine in epileptic patients using a simple and rapid high performance liquid chromotagraphic technique. Ann Clin Biochem1995;32: 584–8.
4.
PatsalosPN. New antiepileptic drugs. Ann Clin Biochem1999;36: 10–9.
5.
FraserADMacNeilWIsnerAFCamfieldPR. Lamotrigine analysis in serum by high-performance liquid chromatography. Ther Drug Monit1995;17: 174–8.
6.
RenSScheuerMLZhengW. Determination of lamotrigine in biologic materials by a simple and rapid liquid chromatographic method. Ther Drug Monit1998;20: 209–14.
7.
HartAPMazarr-ProoSBlackwellWDasguptaA. A rapid cost-effective high-performance liquid chromatographic (HPLC) assay of serum lamotrigine after liquid—liquid extraction and using HPLC conditions routinely used for analysis of barbiturates. Ther Drug Monit1997;19: 431–5.
FraserAD. New drugs for the treatment of epilepsy. Clin Biochem1996;29: 97–110.
10.
MahmoodITammaraVKBawejaRK. Does percent reduction in seizure frequency correlate with plasma concentration of anticonvulsant drugs? Experience with four anticonvulsant drugs. Clin Pharmacol Ther1998;64: 547–52.
11.
PaschoaDella OEHoogerkampAEdelbroekPMVoskuylRADanhofM. Pharmacokinetic—pharmacodynamic correlation of lamotrigine, flunarizine, loreclezole, CGP40116 and CGP39551 in the cortical stimulation model. Epilepsy Res2000;40: 41–52.
12.
TomsonTJohannessenSI. Therapeutic drug monitoring of the new antiepileptic drugs. Eur J Clin Pharmacol2000;55: 697–705.
13.
BartoliAGuerriniRBelmonteAAlessandriMGGattiGPeruccaE. The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: A prospective study with preliminary assessment of correlations with clinical response. Ther Drug Monit1997;19: 252–60.
14.
KilpatrickESForrestGBrodieMJ. Concentration—effect and concentration—toxicity relations with lamotrigine: A prospective study. Epilepsia1996;37: 534–8.
15.
MorrisRGBlackABHarrisALBattyABSallustioBC. Lamotrigine and therapeutic drug monitoring: Retrospective survey following the introduction of a routine service. Br J Clin Pharmacol1998;46: 547–51.
16.
BottigerYSvenssonJ-OStahleL. Lamotrigine drug interactions in a TDM material. Ther Drug Monit1999;21: 171–4.
17.
GidalBEWeltyTE. Letters to the editor. Epilepsia1997;38:260.
18.
MackayFJWiltonLVPearceGLFreemantleSNMannRD. Safety of long-term lamotrigine in epilepsy. Epilepsia1997;38: 881–6.
19.
BattinoDCrociDGranataTEstienneMPisaniFAvanziniG. Lamotrigine plasma concentrations in children and adults: Influence of age and associated therapy. Ther Drug Monit1997;19: 620–7.
20.
ArmijoJABravoJCuadradoAHerranzJL. Lamotrigine serum concentration-to-dose ratio: Influence of age and concomitant antiepileptic drugs and dosage implications. Ther Drug Monit1999;21: 182–90.
21.
ErikssonA-SHoppuKNergardhABoreusL. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. Epilepsia1996;37: 769–73.
22.
ChenC. Validation of a population pharmacokinetic model for adjunctive lamotrigine therapy in children. Br J Clin Pharmacol2000;50: 135–45.
23.
MattsonRH. Antiepileptic drug monitoring; a reappraisal. Epilepsia1995;36(suppl 5):S22–9.
